Development and Clinical Validation of Microbial Markers for the Early Detection of Digestive Cancers

Our mission is to deliver technological solutions that enable faster, more reliable and cost‑effective medical diagnostics compared with current clinical methods. At the core of this mission lies GoodGut’s consolidated expertise in the study of the human gut microbiota, a key regulator of intestinal immune function and a critical factor in the onset and progression of digestive diseases. This scientific and technological know‑how—developed by a team with a strong track record in biomedical research and entrepreneurship—provides a robust foundation for generating high‑value intellectual property and for designing novel, accessible and economically sustainable tools that address urgent clinical needs across Europe.

Building on this foundation, we are committed to forming a strong, multidisciplinary consortium with partners who share our ambition to advance microbiome‑driven innovations for digestive cancer diagnostics. By pooling complementary strengths—ranging from clinical cohort access and high‑throughput sequencing to bioinformatics, molecular assays and clinical validation frameworks—we aim to create a collaborative environment capable of delivering tangible impact. Together, the consortium will identify, define and clinically validate microbial biomarkers associated with digestive cancers. This will be achieved by integrating microbiome profiling with targeted molecular approaches to characterise disease‑associated bacterial signatures and rigorously assess their robustness, reproducibility and clinical relevance.

Through this coordinated effort, our shared goal is to generate reliable, non‑invasive microbiome‑based tools that support early cancer detection, risk stratification and improved clinical decision‑making. By aligning scientific excellence with translational capacity, we seek to contribute meaningfully to earlier diagnosis, better patient outcomes and the long‑term sustainability of European healthcare systems.